Company News
Shukra Pharma Seeks Shareholder Approval for ₹16.51 Cr Warrant Issue
Board approved seeking fresh shareholder approval via EGM on July 06, 2026 for preferential issue of 46.43 lakh convertible equity warrants to promoters.
Revised warrant price set at ₹35.56 each, aggr
